Our Approach

At Alivexis, we are making breakthrough discoveries in small-molecule targeted therapeutics by combining our three strengths: (1) our unique core biology insights; (2) our integrated drug discovery platform; and (3) our resulting pipeline of proprietary drug discovery programs.

Alivexis is focused on small-molecule therapeutics discovery to address current and future medical needs. We are an integrated drug discovery company with a unique portfolio of drug discovery projects, through deep understanding and experience in drug discovery, coupled with the latest cutting-edge drug discovery platform. Our purpose is to efficiently discover novel clinical candidate molecules with superior and differentiated patient efficacy profiles and improved safety. We welcome partners who can help take our candidate molecules through clinical trials together to ultimately deliver new medicines to patients in need.